CDK12 and ovarian carcinoma: The polymorphisms of genes involved in the upstreamof DDR investigated in this study were not associated with PFS and/or OS in this cohort of ovarian patients; in addition, our data highlight the importance of CDK12 polymorphism as a possible prognostic biomarker in ovarian cancer.